What is it?
- Hepatitis C is a virus that causes inflammation of the liver.
- Hepatitis C can lead to cirrhosis and liver cancer in chronic illness
How is it transmitted?
- Most common form of transmission is Blood to blood contact
- Less common is vertical transmission – mother to baby
Activities which place people at risk
- Sharing injecting and auxiliary injecting equipment
- Tattooing and skin piercing with contaminated equipment
- Sharing toothbrushes, razors, and even combs
Short term effects
- May present as mild, flu-like illness
- Rare to experience an acute illness
Long term effects
- 75% of people develop long-term illness and remain infectious to others
and if untreated can develop
- Symptoms may be mild to severe and include fatigue, nausea, muscle pain, abdominal discomfort, and low mood
- No sharing of all injecting and auxiliary equipment
- Ensure sterile equipment for tattooing and skin piercing
- Follow Universal Precautions when managing body fluids
- Avoid sharing toothbrushes, razors, and combs
- Antibody test – This is the most common test. It checks if you have you ever been exposed to hepatitis C. It can take 6 weeks to 3 months before hepatitis C antibodies show up in a test after exposure. This test does not tell you if you have active virus.
- PCR/RNA Test – There are 3 types.
- Checks if you have active virus
- Checks your viral load, and
- Checks your genotype
- Fibroscan – checks the stiffness of your liver, which provides indications of fibrosis and cirrhosis of the liver
- Other less common tests include ultrasound, ALT levels and rarely these days, biopsy
- Getting a periodic Fibroscan and/or ultrasound will allow you to monitor you liver health
- If your liver health shows significant damage you may need to consider treatment
New treatments for hep C, called DAAs (direct acting antiviral’s) became available from the 1 March 2016. The actual medicines are free but you will be charged the usual co-payment paid for a prescription. This is currently $38.30 per month for general patients and $6.20 per month if you have a Health Care or Pension Card. There are no restrictions based on history or current injecting practice or a person’s level of liver damage.
They are different to previous treatment in several ways:
- Higher cure rate 95%, or more, for people who take them (even if you have cirrhosis)
- Have minimal side-effects
- Treatment only lasts 12 weeks (in most cases)
- From one/two pills a day (no injections required).
Clearing hep C reduces liver inflammation and can help reverse fibrosis and even cirrhosis. Knowing that you are no longer hep C positive means you no longer have to worry about passing on the virus to someone else.
The easiest way to get onto treatment is to simply visit your GP or Prescriber and be assessed for treatment. Being assessed involves full blood tests and assessment of liver damage (Fibroscan)
Those people who have advanced liver damage, such as cirrhosis, will be referred for treatment by a specialist (Liver Clinic)(this is because people who have cirrhosis also need long term monitoring for liver cancer even when they clear their hep C).
If you see your GP for treatment all you have to do is take your prescription to a pharmacy. Not all Pharmacies will carry the drugs and will need to order them in for you after they ask for the prescription first .
New treatment for Hepatitis C
- If you have hep C genotype 1, there are several treatment options: a course of Harvoni pills; a course of both Sovaldi and Daklinza pills (taken together); a course of VIEKIRA PAK pills; or VIEKIRA PAK and ribavirin pills. These options offer around 95-97% success rate (chance of cure).
- If you have hep C genotype 2, treatment involves Sovaldi and Ibavyr direct acting antiviral pills. This option offers around 95% success rate (chance of cure).
- If you have hep C genotype 3, there are two treatment options. The first option is a course of both Sovaldi and Daklinza direct acting antiviral pills, and the second option is a course of both Sovaldi and Ibavyr direct acting antiviral pills (taken together). Both options offer around 95% success rate.
- If you have hep C genotypes 4 and 6 are currently offered Sovaldi pills taken with peginterferon and ribavirin. This option offers more than 90% success rate (chance of cure).
- If you have hep C genotypes 1& 3 then you will be offered Savaldi and Daklinza direct acting antivirals pills you have 95% chance of clearing the virus.
Information on Hepatitis C
- World Hepatitis Alliance (WHA)
- Hepatitis Australia
- Hepatitis Council of Queensland
- Hepatitis NSW
- Hepatitis ACT
- Hepatitis Victoria
- Tasmanian Council on Aids, Hepatitis and Related Diseases (TasCAHARD)
- Hepatitis C Council of South Australia
- Hepatitis WA
- Northern Territory Aids and Hepatitis Council (NTAHC)
- World Hepatitis Day Website
- Multilingual Website on HIV/AIDS And Hepatitis C